HEADER HYDROLASE/HYDROLASE INHIBITOR 20-AUG-11 3TI8 TITLE CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH TITLE 2 LANINAMIVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAMINIDASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 79-473; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 385582; SOURCE 4 STRAIN: A/DUCK/ALBERTA/60/1976 H12N5; SOURCE 5 GENE: NA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS 6-BLADED BETA-PROPELLER, CALCIUM BINDING, GLYCOSYLATION, ANTIVIRAL, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.J.VAVRICKA,Q.LI,Y.WU,J.QI,M.WANG,Y.LIU,F.GAO,J.LIU,E.FENG,J.HE, AUTHOR 2 J.WANG,H.LIU,H.JIANG,G.F.GAO REVDAT 4 13-NOV-24 3TI8 1 REMARK REVDAT 3 01-NOV-23 3TI8 1 HETSYN REVDAT 2 29-JUL-20 3TI8 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 16-NOV-11 3TI8 0 JRNL AUTH C.J.VAVRICKA,Q.LI,Y.WU,J.QI,M.WANG,Y.LIU,F.GAO,J.LIU,E.FENG, JRNL AUTH 2 J.HE,J.WANG,H.LIU,H.JIANG,G.F.GAO JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSIS OF LANINAMIVIR AND ITS JRNL TITL 2 OCTANOATE PRODRUG REVEALS GROUP SPECIFIC MECHANISMS FOR JRNL TITL 3 INFLUENZA NA INHIBITION JRNL REF PLOS PATHOG. V. 7 02249 2011 JRNL REFN ISSN 1553-7366 JRNL PMID 22028647 JRNL DOI 10.1371/JOURNAL.PPAT.1002249 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.5_2) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.120 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 105988 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.129 REMARK 3 R VALUE (WORKING SET) : 0.127 REMARK 3 FREE R VALUE : 0.161 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 5293 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.8093 - 4.9709 1.00 3633 167 0.1583 0.1504 REMARK 3 2 4.9709 - 3.9467 1.00 3525 188 0.1147 0.1312 REMARK 3 3 3.9467 - 3.4481 1.00 3488 211 0.1197 0.1373 REMARK 3 4 3.4481 - 3.1330 1.00 3472 199 0.1302 0.1547 REMARK 3 5 3.1330 - 2.9085 1.00 3508 171 0.1334 0.1638 REMARK 3 6 2.9085 - 2.7371 1.00 3462 189 0.1335 0.1630 REMARK 3 7 2.7371 - 2.6000 1.00 3518 167 0.1381 0.1777 REMARK 3 8 2.6000 - 2.4869 0.99 3436 192 0.1311 0.1638 REMARK 3 9 2.4869 - 2.3911 0.99 3453 151 0.1245 0.1538 REMARK 3 10 2.3911 - 2.3086 0.99 3469 177 0.1190 0.1515 REMARK 3 11 2.3086 - 2.2365 0.99 3459 159 0.1127 0.1538 REMARK 3 12 2.2365 - 2.1725 0.99 3459 170 0.1049 0.1465 REMARK 3 13 2.1725 - 2.1153 0.99 3422 174 0.1039 0.1460 REMARK 3 14 2.1153 - 2.0637 0.98 3461 159 0.1053 0.1415 REMARK 3 15 2.0637 - 2.0168 0.98 3379 187 0.1071 0.1509 REMARK 3 16 2.0168 - 1.9739 0.97 3391 192 0.1065 0.1637 REMARK 3 17 1.9739 - 1.9344 0.96 3354 180 0.1050 0.1506 REMARK 3 18 1.9344 - 1.8979 0.97 3341 160 0.1069 0.1728 REMARK 3 19 1.8979 - 1.8640 0.96 3330 183 0.1069 0.1458 REMARK 3 20 1.8640 - 1.8324 0.96 3343 188 0.1071 0.1743 REMARK 3 21 1.8324 - 1.8029 0.95 3265 166 0.1075 0.1584 REMARK 3 22 1.8029 - 1.7751 0.95 3260 190 0.1069 0.1738 REMARK 3 23 1.7751 - 1.7490 0.94 3208 190 0.1051 0.1579 REMARK 3 24 1.7490 - 1.7244 0.94 3257 171 0.1075 0.1639 REMARK 3 25 1.7244 - 1.7011 0.91 3168 175 0.1189 0.2027 REMARK 3 26 1.7011 - 1.6790 0.92 3169 165 0.1278 0.1936 REMARK 3 27 1.6790 - 1.6580 0.91 3191 164 0.1281 0.1956 REMARK 3 28 1.6580 - 1.6380 0.90 3087 167 0.1311 0.2092 REMARK 3 29 1.6380 - 1.6190 0.90 3103 171 0.1423 0.2203 REMARK 3 30 1.6190 - 1.6008 0.89 3084 170 0.1502 0.2290 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 33.14 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 13.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.51290 REMARK 3 B22 (A**2) : 0.51290 REMARK 3 B33 (A**2) : -1.02570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6419 REMARK 3 ANGLE : 1.008 8700 REMARK 3 CHIRALITY : 0.071 951 REMARK 3 PLANARITY : 0.005 1115 REMARK 3 DIHEDRAL : 22.373 2337 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3TI8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067509. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NE3A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 110000 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3SAL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES (PH 7.5), 12% W/V REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -104.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -79.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 112.56300 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -112.56300 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 -112.56300 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 112.56300 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 688 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 756 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 823 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 635 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1009 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1161 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 471 REMARK 465 MET B 471 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 111 -37.76 -130.15 REMARK 500 ALA A 177 132.50 -171.95 REMARK 500 ASP A 200 50.18 -165.01 REMARK 500 THR A 225 -155.76 -137.63 REMARK 500 PHE A 270 64.66 -150.36 REMARK 500 TRP A 295 -100.55 -117.51 REMARK 500 THR A 387 45.54 -78.16 REMARK 500 SER A 404 -134.87 -110.72 REMARK 500 TRP A 456 -162.12 -163.45 REMARK 500 ALA B 177 132.70 -171.91 REMARK 500 ASP B 200 49.07 -163.05 REMARK 500 THR B 225 -153.67 -136.91 REMARK 500 ALA B 250 -168.89 -123.92 REMARK 500 CYS B 291 -169.66 -123.40 REMARK 500 TRP B 295 -99.54 -117.68 REMARK 500 THR B 387 45.43 -78.14 REMARK 500 SER B 404 -136.02 -110.51 REMARK 500 TRP B 456 -163.88 -164.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 601 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 1 O REMARK 620 2 HOH A 8 O 78.9 REMARK 620 3 ASP A 293 O 97.9 174.4 REMARK 620 4 GLY A 297 O 80.3 96.5 87.5 REMARK 620 5 ASP A 324 OD2 166.3 92.1 91.8 90.6 REMARK 620 6 TYR A 347B O 82.8 85.2 89.9 162.4 106.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 601 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 6 O REMARK 620 2 HOH B 52 O 82.2 REMARK 620 3 ASP B 293 O 95.7 176.8 REMARK 620 4 GLY B 297 O 78.5 94.8 87.2 REMARK 620 5 ASP B 324 OD2 167.5 91.3 91.2 91.5 REMARK 620 6 TYR B 347B O 83.6 86.6 90.7 161.6 106.8 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SAL RELATED DB: PDB REMARK 900 INFLUENZA A VIRUS NEURAMINIDASE N5 HAS AN EXTENDED 150-CAVITY REMARK 900 RELATED ID: 3SAN RELATED DB: PDB REMARK 900 INFLUENZA A VIRUS NEURAMINIDASE N5 HAS AN EXTENDED 150-CAVITY REMARK 900 RELATED ID: 3TI3 RELATED DB: PDB REMARK 900 RELATED ID: 3TI4 RELATED DB: PDB REMARK 900 RELATED ID: 3TI5 RELATED DB: PDB REMARK 900 RELATED ID: 3TI6 RELATED DB: PDB REMARK 900 RELATED ID: 3TIA RELATED DB: PDB REMARK 900 RELATED ID: 3TIB RELATED DB: PDB REMARK 900 RELATED ID: 3TIC RELATED DB: PDB DBREF 3TI8 A 82 471 UNP A1ILL9 A1ILL9_I76A2 79 473 DBREF 3TI8 B 82 471 UNP A1ILL9 A1ILL9_I76A2 79 473 SEQRES 1 A 395 PRO GLU PHE LEU ASN ASN THR GLU PRO LEU CYS ASN VAL SEQRES 2 A 395 SER GLY PHE ALA ILE VAL SER LYS ASP ASN GLY ILE ARG SEQRES 3 A 395 ILE GLY SER ARG GLY HIS VAL PHE VAL ILE ARG GLU PRO SEQRES 4 A 395 PHE VAL ALA CYS GLY PRO THR GLU CYS ARG THR PHE PHE SEQRES 5 A 395 LEU THR GLN GLY ALA LEU LEU ASN ASP LYS HIS SER ASN SEQRES 6 A 395 ASN THR VAL LYS ASP ARG SER PRO TYR ARG ALA LEU MET SEQRES 7 A 395 SER VAL PRO LEU GLY SER SER PRO ASN ALA TYR GLN ALA SEQRES 8 A 395 LYS PHE GLU SER VAL ALA TRP SER ALA THR ALA CYS HIS SEQRES 9 A 395 ASP GLY LYS LYS TRP LEU ALA VAL GLY ILE SER GLY ALA SEQRES 10 A 395 ASP ASP ASP ALA TYR ALA VAL ILE HIS TYR GLY GLY MET SEQRES 11 A 395 PRO THR ASP VAL VAL ARG SER TRP ARG LYS GLN ILE LEU SEQRES 12 A 395 ARG THR GLN GLU SER SER CYS VAL CYS MET ASN GLY ASN SEQRES 13 A 395 CYS TYR TRP VAL MET THR ASP GLY PRO ALA ASN SER GLN SEQRES 14 A 395 ALA SER TYR LYS ILE PHE LYS SER HIS GLU GLY MET VAL SEQRES 15 A 395 THR ASN GLU ARG GLU VAL SER PHE GLN GLY GLY HIS ILE SEQRES 16 A 395 GLU GLU CYS SER CYS TYR PRO ASN LEU GLY LYS VAL GLU SEQRES 17 A 395 CYS VAL CYS ARG ASP ASN TRP ASN GLY MET ASN ARG PRO SEQRES 18 A 395 ILE LEU ILE PHE ASP GLU ASP LEU ASP TYR GLU VAL GLY SEQRES 19 A 395 TYR LEU CYS ALA GLY ILE PRO THR ASP THR PRO ARG VAL SEQRES 20 A 395 GLN ASP SER SER PHE THR GLY SER CYS THR ASN ALA VAL SEQRES 21 A 395 GLY GLY SER GLY THR ASN ASN TYR GLY VAL LYS GLY PHE SEQRES 22 A 395 GLY PHE ARG GLN GLY ASN SER VAL TRP ALA GLY ARG THR SEQRES 23 A 395 VAL SER ILE SER SER ARG SER GLY PHE GLU ILE LEU LEU SEQRES 24 A 395 ILE GLU ASP GLY TRP ILE ARG THR SER LYS THR ILE VAL SEQRES 25 A 395 LYS LYS VAL GLU VAL LEU ASN ASN LYS ASN TRP SER GLY SEQRES 26 A 395 TYR SER GLY ALA PHE THR ILE PRO ILE THR MET THR SER SEQRES 27 A 395 LYS GLN CYS LEU VAL PRO CYS PHE TRP LEU GLU MET ILE SEQRES 28 A 395 ARG GLY LYS PRO GLU GLU ARG THR SER ILE TRP THR SER SEQRES 29 A 395 SER SER SER THR VAL PHE CYS GLY VAL SER SER GLU VAL SEQRES 30 A 395 PRO GLY TRP SER TRP ASP ASP GLY ALA ILE LEU PRO PHE SEQRES 31 A 395 ASP ILE ASP LYS MET SEQRES 1 B 395 PRO GLU PHE LEU ASN ASN THR GLU PRO LEU CYS ASN VAL SEQRES 2 B 395 SER GLY PHE ALA ILE VAL SER LYS ASP ASN GLY ILE ARG SEQRES 3 B 395 ILE GLY SER ARG GLY HIS VAL PHE VAL ILE ARG GLU PRO SEQRES 4 B 395 PHE VAL ALA CYS GLY PRO THR GLU CYS ARG THR PHE PHE SEQRES 5 B 395 LEU THR GLN GLY ALA LEU LEU ASN ASP LYS HIS SER ASN SEQRES 6 B 395 ASN THR VAL LYS ASP ARG SER PRO TYR ARG ALA LEU MET SEQRES 7 B 395 SER VAL PRO LEU GLY SER SER PRO ASN ALA TYR GLN ALA SEQRES 8 B 395 LYS PHE GLU SER VAL ALA TRP SER ALA THR ALA CYS HIS SEQRES 9 B 395 ASP GLY LYS LYS TRP LEU ALA VAL GLY ILE SER GLY ALA SEQRES 10 B 395 ASP ASP ASP ALA TYR ALA VAL ILE HIS TYR GLY GLY MET SEQRES 11 B 395 PRO THR ASP VAL VAL ARG SER TRP ARG LYS GLN ILE LEU SEQRES 12 B 395 ARG THR GLN GLU SER SER CYS VAL CYS MET ASN GLY ASN SEQRES 13 B 395 CYS TYR TRP VAL MET THR ASP GLY PRO ALA ASN SER GLN SEQRES 14 B 395 ALA SER TYR LYS ILE PHE LYS SER HIS GLU GLY MET VAL SEQRES 15 B 395 THR ASN GLU ARG GLU VAL SER PHE GLN GLY GLY HIS ILE SEQRES 16 B 395 GLU GLU CYS SER CYS TYR PRO ASN LEU GLY LYS VAL GLU SEQRES 17 B 395 CYS VAL CYS ARG ASP ASN TRP ASN GLY MET ASN ARG PRO SEQRES 18 B 395 ILE LEU ILE PHE ASP GLU ASP LEU ASP TYR GLU VAL GLY SEQRES 19 B 395 TYR LEU CYS ALA GLY ILE PRO THR ASP THR PRO ARG VAL SEQRES 20 B 395 GLN ASP SER SER PHE THR GLY SER CYS THR ASN ALA VAL SEQRES 21 B 395 GLY GLY SER GLY THR ASN ASN TYR GLY VAL LYS GLY PHE SEQRES 22 B 395 GLY PHE ARG GLN GLY ASN SER VAL TRP ALA GLY ARG THR SEQRES 23 B 395 VAL SER ILE SER SER ARG SER GLY PHE GLU ILE LEU LEU SEQRES 24 B 395 ILE GLU ASP GLY TRP ILE ARG THR SER LYS THR ILE VAL SEQRES 25 B 395 LYS LYS VAL GLU VAL LEU ASN ASN LYS ASN TRP SER GLY SEQRES 26 B 395 TYR SER GLY ALA PHE THR ILE PRO ILE THR MET THR SER SEQRES 27 B 395 LYS GLN CYS LEU VAL PRO CYS PHE TRP LEU GLU MET ILE SEQRES 28 B 395 ARG GLY LYS PRO GLU GLU ARG THR SER ILE TRP THR SER SEQRES 29 B 395 SER SER SER THR VAL PHE CYS GLY VAL SER SER GLU VAL SEQRES 30 B 395 PRO GLY TRP SER TRP ASP ASP GLY ALA ILE LEU PRO PHE SEQRES 31 B 395 ASP ILE ASP LYS MET MODRES 3TI8 ASN A 146 ASN GLYCOSYLATION SITE MODRES 3TI8 ASN B 93 ASN GLYCOSYLATION SITE MODRES 3TI8 ASN A 93 ASN GLYCOSYLATION SITE MODRES 3TI8 ASN B 146 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET CA A 601 1 HET NAG A 801 14 HET NAG A 803 14 HET LNV A 901 24 HET CA B 601 1 HET LNV B 901 24 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM LNV 5-ACETAMIDO-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5- HETNAM 2 LNV TRIDEOXY-7-O-METHYL-D-GLYCERO-D-GALACTO-NON-2-ENONIC HETNAM 3 LNV ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN LNV 5-(ACETYLAMINO)-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5- HETSYN 2 LNV TRIDEOXY-7-O-METHYL-D-GLYCERO-D-GALACTO-NON-2-ENONIC HETSYN 3 LNV ACID; LANINAMIVIR FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 5 CA 2(CA 2+) FORMUL 8 LNV 2(C13 H22 N4 O7) FORMUL 11 HOH *1162(H2 O) HELIX 1 1 ASN A 104 GLY A 109 1 6 HELIX 2 2 ASP A 142 ASN A 146 5 5 HELIX 3 3 GLN A 329 PHE A 333 5 5 HELIX 4 4 PRO A 413 SER A 414 1 6 HELIX 5 5 PHE A 466 LYS A 470 5 5 HELIX 6 6 ASN B 104 GLY B 109 1 6 HELIX 7 7 ASP B 142 ASN B 146 5 5 HELIX 8 8 GLN B 329 PHE B 333 5 5 HELIX 9 9 PRO B 413 SER B 414 1 6 HELIX 10 10 PHE B 466 LYS B 470 5 5 SHEET 1 A 4 GLY A 96 LYS A 102 0 SHEET 2 A 4 THR A 439 VAL A 449 -1 O VAL A 445 N VAL A 100 SHEET 3 A 4 VAL A 419 GLY A 429 -1 N PRO A 420 O GLY A 448 SHEET 4 A 4 SER A 407 ILE A 412 -1 N PHE A 410 O CYS A 421 SHEET 1 B 4 PHE A 115 CYS A 124 0 SHEET 2 B 4 CYS A 129 LEU A 139 -1 O PHE A 132 N PHE A 121 SHEET 3 B 4 ALA A 157 PRO A 162 -1 O ALA A 157 N THR A 135 SHEET 4 B 4 LYS A 172 VAL A 176 -1 O LYS A 172 N SER A 160 SHEET 1 C 4 SER A 179 HIS A 184 0 SHEET 2 C 4 TRP A 189 SER A 195 -1 O LEU A 190 N CYS A 183 SHEET 3 C 4 TYR A 202 TYR A 207 -1 O HIS A 206 N ALA A 191 SHEET 4 C 4 MET A 210 ARG A 216 -1 O THR A 212 N ILE A 205 SHEET 1 D 4 VAL A 231 MET A 233 0 SHEET 2 D 4 ASN A 236 ASP A 243 -1 O TYR A 238 N VAL A 231 SHEET 3 D 4 SER A 251 HIS A 258 -1 O PHE A 255 N TRP A 239 SHEET 4 D 4 MET A 261 VAL A 268 -1 O VAL A 268 N TYR A 252 SHEET 1 E 4 GLU A 276 ASN A 283 0 SHEET 2 E 4 LYS A 286 ARG A 292 -1 O GLU A 288 N TYR A 281 SHEET 3 E 4 PRO A 301 PHE A 305 -1 O PHE A 305 N VAL A 287 SHEET 4 E 4 TYR A 312 TYR A 316 -1 O GLU A 313 N ILE A 304 SHEET 1 F 4 GLY A 353 GLN A 356 0 SHEET 2 F 4 SER A 359 ARG A 364 -1 O SER A 359 N GLN A 356 SHEET 3 F 4 SER A 372 ILE A 379 -1 O LEU A 377 N ALA A 362 SHEET 4 F 4 ILE A 391 TRP A 403 -1 O LEU A 398 N PHE A 374 SHEET 1 G 4 GLY B 96 LYS B 102 0 SHEET 2 G 4 THR B 439 VAL B 449 -1 O VAL B 445 N VAL B 100 SHEET 3 G 4 VAL B 419 GLY B 429 -1 N PRO B 420 O GLY B 448 SHEET 4 G 4 SER B 407 ILE B 412 -1 N PHE B 410 O CYS B 421 SHEET 1 H 4 PHE B 115 CYS B 124 0 SHEET 2 H 4 CYS B 129 LEU B 139 -1 O PHE B 132 N PHE B 121 SHEET 3 H 4 ALA B 157 PRO B 162 -1 O ALA B 157 N THR B 135 SHEET 4 H 4 LYS B 172 VAL B 176 -1 O LYS B 172 N SER B 160 SHEET 1 I 4 SER B 179 HIS B 184 0 SHEET 2 I 4 TRP B 189 SER B 195 -1 O LEU B 190 N CYS B 183 SHEET 3 I 4 TYR B 202 TYR B 207 -1 O HIS B 206 N ALA B 191 SHEET 4 I 4 MET B 210 ARG B 216 -1 O MET B 210 N TYR B 207 SHEET 1 J 4 VAL B 231 MET B 233 0 SHEET 2 J 4 ASN B 236 ASP B 243 -1 O TYR B 238 N VAL B 231 SHEET 3 J 4 SER B 251 HIS B 258 -1 O PHE B 255 N TRP B 239 SHEET 4 J 4 MET B 261 VAL B 268 -1 O VAL B 268 N TYR B 252 SHEET 1 K 4 GLU B 276 ASN B 283 0 SHEET 2 K 4 LYS B 286 ARG B 292 -1 O GLU B 288 N TYR B 281 SHEET 3 K 4 PRO B 301 PHE B 305 -1 O PHE B 305 N VAL B 287 SHEET 4 K 4 TYR B 312 TYR B 316 -1 O GLU B 313 N ILE B 304 SHEET 1 L 4 GLY B 353 GLN B 356 0 SHEET 2 L 4 SER B 359 ARG B 364 -1 O SER B 359 N GLN B 356 SHEET 3 L 4 SER B 372 ILE B 379 -1 O ILE B 379 N VAL B 360 SHEET 4 L 4 ILE B 391 TRP B 403 -1 O VAL B 395 N ILE B 376 SSBOND 1 CYS A 92 CYS A 417 1555 1555 2.04 SSBOND 2 CYS A 124 CYS A 129 1555 1555 2.03 SSBOND 3 CYS A 183 CYS A 230 1555 1555 2.04 SSBOND 4 CYS A 232 CYS A 237 1555 1555 2.05 SSBOND 5 CYS A 278 CYS A 291 1555 1555 2.07 SSBOND 6 CYS A 280 CYS A 289 1555 1555 2.05 SSBOND 7 CYS A 318 CYS A 337 1555 1555 2.04 SSBOND 8 CYS A 421 CYS A 447 1555 1555 2.04 SSBOND 9 CYS B 92 CYS B 417 1555 1555 2.04 SSBOND 10 CYS B 124 CYS B 129 1555 1555 2.03 SSBOND 11 CYS B 183 CYS B 230 1555 1555 2.04 SSBOND 12 CYS B 232 CYS B 237 1555 1555 2.05 SSBOND 13 CYS B 278 CYS B 291 1555 1555 2.07 SSBOND 14 CYS B 280 CYS B 289 1555 1555 2.05 SSBOND 15 CYS B 318 CYS B 337 1555 1555 2.04 SSBOND 16 CYS B 421 CYS B 447 1555 1555 2.04 LINK ND2 ASN A 93 C1 NAG A 801 1555 1555 1.44 LINK ND2 ASN A 146 C1 NAG A 803 1555 1555 1.44 LINK ND2 ASN B 93 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 146 C1 NAG D 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O HOH A 1 CA CA A 601 1555 1555 2.49 LINK O HOH A 8 CA CA A 601 1555 1555 2.50 LINK O ASP A 293 CA CA A 601 1555 1555 2.37 LINK O GLY A 297 CA CA A 601 1555 1555 2.45 LINK OD2 ASP A 324 CA CA A 601 1555 1555 2.36 LINK O TYR A 347B CA CA A 601 1555 1555 2.45 LINK O HOH B 6 CA CA B 601 1555 1555 2.48 LINK O HOH B 52 CA CA B 601 1555 1555 2.49 LINK O ASP B 293 CA CA B 601 1555 1555 2.37 LINK O GLY B 297 CA CA B 601 1555 1555 2.45 LINK OD2 ASP B 324 CA CA B 601 1555 1555 2.38 LINK O TYR B 347B CA CA B 601 1555 1555 2.41 CISPEP 1 THR A 325 PRO A 326 0 5.44 CISPEP 2 LYS A 430 PRO A 431 0 1.65 CISPEP 3 LEU A 464 PRO A 465 0 1.22 CISPEP 4 THR B 325 PRO B 326 0 4.06 CISPEP 5 LYS B 430 PRO B 431 0 2.29 CISPEP 6 LEU B 464 PRO B 465 0 -0.31 CRYST1 112.563 112.563 66.809 90.00 90.00 90.00 P 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008884 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008884 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014968 0.00000